| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |